Waterdrop Inc. is significantly undervalued, with expected FCF growth driven by AI-driven customer experience, proprietary CRM, and technical connections with large insurance carriers. The company's medical crowdfunding model appears to be a key catalyst for future net sales and income growth. Risks include operating in China, potential failed mergers and acquisitions, and regulatory changes, but the stock repurchase program may boost demand and stock price.
Waterdrop Inc. (NYSE:WDH ) Q2 2024 Earnings Conference Call September 4, 2024 8:00 AM ET Company Participants Tracy Lisang - IR Peng Shen - Founder, Chairman and CEO Ran Wei - Director and GM of Insurance Business Xu Xiaoying - Head of Finance Department Jasmine Li - Board Secretary Tracy Lisang Good morning, everyone. This is Tracy Lisang with Waterdrop Investor Relations.